Key Points: While longevity-oriented investments burgeoned from $525 million in 2013 to $9.26 billion in 2021, funding has slumped over the last year. Accordingly, investments in the business of longevity only totaled about $3.01 billion in 2023. The decline in longevity-related investments comes amid high interest rates and economic worries. However, some experts predict a… Continue reading Exploring Longevity Drugs in an Era of Slumping Investments and Rising Doubt
Category: Industry
Learning from Incredibly Resilient Creatures to Develop Anti-Aging Drugs
Key Points: Dr. Ashley Zehnder is the CEO of the aging research biotech company FaunaBio and a veterinarian scientist at the intersection of animal biology and human health. Her company has utilized a slew of hibernating animals that overcome extreme physiological degeneration during the months that they hibernate for aging research. With their study of… Continue reading Learning from Incredibly Resilient Creatures to Develop Anti-Aging Drugs
Meet the Latest Platform in the US Providing Longevity and Healthspan Consultation — Lifeforce
Those behind Los Angeles-based telehealth provider Lifeforce, including CEO Dugal Bain-Kim and co-founders Tony Robbins, Dr. Peter Diamandis, and tennis star Serena Williams, want to optimize human longevity. To do so, they provide an integrated health augmenting platform where clients are given access to physicians and longevity experts via remote, video conferencing-based (telehealth) programs integrating… Continue reading Meet the Latest Platform in the US Providing Longevity and Healthspan Consultation — Lifeforce
Biotech Startup SirTLab Prepares for Groundbreaking Human Trials of SIRT6-Boosting Therapy
Key Points: Countless animal studies have given credence to our newfound ability to delay aging and chronic disease with just a pill. The only problem is that many of these longevity interventions have yet to be tested on humans. Now Israel-based SirTLab Corporation is taking a huge step forward in solving this conundrum by planning… Continue reading Biotech Startup SirTLab Prepares for Groundbreaking Human Trials of SIRT6-Boosting Therapy
ChatGPT Founder Sam Altman’s New Startup Retro Biosciences Aims to Reverse Aging
Until revealed by MIT Technology Review on March 8th, the identity of the investors who provided $180 million in startup funds to Retro Biosciences was a mystery. Now we know the money came from only one investor— Sam Altman. Altman is the CEO of OpenAI, the artificial intelligence (AI) company behind ChatGPT and now GPT-4,… Continue reading ChatGPT Founder Sam Altman’s New Startup Retro Biosciences Aims to Reverse Aging
Seragon Releases Advanced Aging Intervention Nutraceutical RESTORIN
Key Points After years of development and multiple delays, Seragon finally launched its highly sought-after anti-aging and longevity nutraceutical RESTORIN, previously known as SRN-901N. The Irvine, California-based biopharma company has undergone intense negotiations with multiple leading research institutions to obtain necessary technologies and patent licensing to deliver RESTORIN to the market. The technologies underlying RESTORIN… Continue reading Seragon Releases Advanced Aging Intervention Nutraceutical RESTORIN
New Anti-Aging Supplement Mitopure Promotes Microbiome Health
Highlights: Even if you follow the food pyramid’s guidelines, eating optimal portions of each food group, you still may not get all the necessary nutrients. That happens, in part, because if we don’t have the right mix of microbes in our guts — the microbiome — then we can’t convert food into the nutrients needed… Continue reading New Anti-Aging Supplement Mitopure Promotes Microbiome Health